Concepedia

Olivia Aranha

OA

Statistics

Publications

15

Citations

847

H-Index

13

Active since

1999

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

Wayne State University

Washington University in St. Louis

Mayo Clinic in Florida

Mayo Clinic in Arizona

Olivia Aranha is an author at The Barbara Ann Karmanos Cancer Institute specializing in pharmacology, oncology, and medicine.

ORCID

Publications per year

1999–2025

15

Publications

15

Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.

Olivia Aranha, David P. Wood, F. H. Sarkar · PubMed · 2000 · 123 citations

, , +16

Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study

Andrea Wang‐Gillam, Kian‐Huat Lim, Robert R. McWilliams et al. · Clinical Cancer Research · 2022 · 106 citations · Full text

, , +17

Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis

Olivia Aranha, R Grignon, N Freitas Fernandes et al. · International Journal of Oncology · 2003 · 101 citations

, , +17

Translocation of Bax to mitochondria induces apoptotic cell death in Indole-3-carbinol (I3C) treated breast cancer cells

Khalilur Rahman, Olivia Aranha, Alexey Glazyrin et al. · Oncogene · 2000 · 88 citations

, , +14

Indole-3-Carbinol (I3C) Induces Apoptosis in Tumorigenic but Not in Nontumorigenic Breast Epithelial Cells

KM Wahidur Rahman, Olivia Aranha, Fazlul H. Sarkar · Nutrition and Cancer · 2003 · 86 citations

, , +15

1–5 of 15